05-JUL-2022 6:10

ERLYTX ACCRUAL REPORT - Open and Recently Closed Studies

SWOG/
Support
STUDY R
E
G
O
P
E
N
ARM ACCR.
GOAL
TOTAL
REGS.
REGS.
LAST
12
Month
REGS.
LAST
6
Month
REGS.
LAST
3
Month
REGS.
LAST
30
DAYS
REGS.
LAST
7
DAYS
DATE OF
FIRST
REG.
# of
ACT.
INSTs
# of
CURR
IRBs
SWOG S1609-Rare Tumor, Comb Nivo/Ipi 1 Y 1 Nivolumab + Ipilimumab 818 780 17 3 2 1 0 01/30/2017 400 155
        2 Nivolumab single agent therapy   13 4 1 0 0 0      
            793 21 4 2 1 0      
 
  S2012-Small Cell NEC, Stg IV, Combo Chemo +/- Atezo 1 Y 3 Platinum/Etoposide Only 189 1 1 1 1 1 0 06/28/2022 123 43
            1 1 1 1 1 0      
 
Yes EAY131-MATCH 0 E Total Registrations   1005 6 0 0 0 0 08/21/2015 427 193
            1005 6 0 0 0 0      
 
    1 E Total Registrations   183 5 0 0 0 0 08/21/2015    
            183 5 0 0 0 0      
 
    2 E Total Registrations   8 0 0 0 0 0 08/21/2015    
            8 0 0 0 0 0      
 
    8 E Total Registrations   7 0 0 0 0 0 08/21/2015    
            7 0 0 0 0 0      
 
No AGCT1531-Mult, Stg I-IV, Carbo vs Cisp, Ped &Adult 1 E Total Registrations   1 1 0 0 0 0 10/07/2021 231 110
            1 1 0 0 0 0